Share Search
Visit the Share Search
N4 Pharma Plc Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating Profit / Loss | -1.43 | -1.19 | -1.84 | -1.56 | -0.95 |
| Net Interest | n/a | n/a | n/a | n/a | n/a |
| Pre Tax Profit | -1.43 | -1.19 | -1.84 | -1.57 | -0.95 |
| Post Tax Profit | -1.28 | -1.03 | -1.54 | -1.30 | -0.88 |
| Profit for the Period | -1.28 | -1.03 | -1.54 | -1.30 | -0.88 |
| Equity Holders of Parent Company | -1.27 | -1.03 | -1.54 | -1.30 | -0.88 |
| Minority Interests | -0.01 | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -0.52p | -0.55p | -0.85p | -0.96p | -0.87p |
| Earnings per Share (Diluted) | -0.52p | -0.55p | -0.85p | -0.96p | -0.87p |
| Earnings per Share (Adjusted) | -0.52p | -0.55p | -0.85p | -0.96p | -0.87p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -0.52p | -0.55p | -0.85p | -0.96p | -0.87p |
| Earnings per Share (Diluted) | -0.52p | -0.55p | -0.85p | -0.96p | -0.87p |
| Earnings per Share (Adjusted) | -0.52p | -0.55p | -0.85p | -0.96p | -0.87p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Non-Current Assets | |||||
| Intangible Assets | 0.06 | n/a | n/a | n/a | n/a |
| Property, Plant and Equipment | n/a | n/a | n/a | n/a | n/a |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 0.06 | n/a | n/a | n/a | n/a |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 0.19 | 0.25 | 0.56 | 0.27 | 0.10 |
| Cash at Bank and in Hand | 1.03 | 1.92 | 1.78 | 3.56 | 0.97 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 1.21 | 2.17 | 2.34 | 3.83 | 1.07 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 1.27 | 2.17 | 2.34 | 3.83 | 1.07 |
| Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 0.08 | -0.08 | 0.21 | 0.17 | 0.08 |
| Total Current Liabilities | 0.08 | -0.08 | 0.21 | 0.17 | 0.08 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Net Assets | 1.19 | 2.24 | 2.13 | 3.66 | 0.99 |
| Capital and Reserves | |||||
| Share Capital | 9.35 | 9.21 | 9.00 | 9.00 | 8.68 |
| Share Premium Account | 14.87 | 14.70 | 13.95 | 13.95 | 10.33 |
| Other Reserves | -13.75 | -13.76 | -13.78 | -13.80 | -13.83 |
| Retained Earnings | -9.34 | -8.06 | -7.03 | -5.49 | -4.18 |
| Shareholders Funds | 1.13 | 2.09 | 2.13 | 3.66 | 0.99 |
| Minority Interests / Other Equity | 0.07 | n/a | n/a | n/a | n/a |
| Total Equity | 1.19 | 2.24 | 2.13 | 3.66 | 0.99 |
| 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | |
| Operating Margin | -71,250.00% | n/a% | n/a% | n/a% | n/a% |
| Return on Capital Employed | -125.77% | -53.16% | -86.55% | -42.83% | -95.95% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 0.42p | 0.83p | 0.79p | 1.36p | 0.37p |